Concepedia
Statistics
Publications
13
Citations
362
H-Index
12
Active since
2002
Affiliations
Samsung Medical Center(Current)
Sungkyunkwan University
Samsung (South Korea)
Osaka Prefecture University
Korea Research Institute of Chemical Technology
Doo-Pyo Hong is an author at Samsung Medical Center specializing in oncology, medicine, and malignant neoplasms.
Publications per year
2002–2020
SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma
Zhengyun Zhang, Doo-Pyo Hong, Seung Hoon Nam et al. · Journal of Hepatology · 2014 · 70 citations
Medicine, Molecular Biology, Oncology +14
Anti-tumor effects of anti-PD-1 antibody, pembrolizumab, in humanized NSG PDX mice xenografted with dedifferentiated liposarcoma
Bongkum Choi, Joo Sang Lee, Sung Joo Kim et al. · Cancer Letters · 2020 · 45 citations
Medicine, Oncology, Pharmacology +16
Comprehensive analysis of differential gene expression profiles on carbon tetrachloride-induced rat liver injury and regeneration
Heekyoung Chung, Doo-Pyo Hong, Ji‐Youn Jung et al. · Toxicology and Applied Pharmacology · 2004 · 42 citations
Life Sciences, Molecular Biology, Toxicology +16
Dryopteris crassirhizoma has anti-cancer effects through both extrinsic and intrinsic apoptotic pathways and G0/G1 phase arrest in human prostate cancer cells
Sung-Ho Chang, Jae‐Ho Bae, Doo-Pyo Hong et al. · Journal of Ethnopharmacology · 2010 · 40 citations
Medicine, Cancer Biology, Oncology +14
Atm heterozygous deficiency enhances development of mammary carcinomas in p53heterozygous knockout mice
Seiichi Umesako, Kae Fujisawa, Sayoko Iiga et al. · Breast Cancer Research · 2004 · 32 citations · Full text
Medicine, Genetics, Oncology +15
1–5 of 13